Schedule 13G ownership disclosure

VISTAGEN THERAPEUTICS INC

Security class unavailable · CUSIP: 92840H202

Event date: 2017-12-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,333,333
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-074209
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Dec 20, 2017
Reporting period
Dec 11, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub